Effects of initial use of half-maximal dose rosiglitazone-metformin combination therapy, compared with maximum dose rosiglitazone or metformin, on glucose metabolism in type 2 diabetes mellitus

被引：0
|
作者：
Choe, Charles
Christiansen, Louis
Edelman, Steven
Mudaliar, Sunder
Henry, Robert R.
机构：
来源：
DIABETES | 2006年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A107 / A107
页数：1
相关论文
共 50 条
  • [41] Effects of Rosiglitazone/Metformin Fixed-Dose Combination Therapy and Metformin Monotherapy on Serum Vaspin, Adiponectin and IL-6 Levels in Drug-Naive Patients with Type 2 Diabetes
    Kadoglou, N. P. E.
    Kapelouzou, A.
    Tsanikidis, H.
    Vitta, I.
    Liapis, C. D.
    Sailer, N.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2011, 119 (02) : 63 - 68
  • [42] Coronary heart disease experience and time to insulin with rosiglitazone-metformin combination in overweight and obese patients with Type 2 diabetes in the UK
    Shearer, AT
    Bagust, A
    DIABETOLOGIA, 2004, 47 : A419 - A420
  • [43] Daily insulin dose in combination with metformin or/and glimepiride in type 2 Diabetes Mellitus
    Kabadi, UM
    Kabadi, MM
    DIABETES, 2002, 51 : A102 - A102
  • [44] Benefits of combination with rosiglitazone (RSG) and metformin (MET) over uptitration to maximal dose MET in previously drug-naive type 2 diabetes mellitus (T2DM) patients
    Garber, A
    Wooddell, MJ
    Strow, LJ
    Waterhouse, BR
    Cobitz, AR
    DIABETES, 2004, 53 : A475 - A475
  • [45] Triple combination therapy with sitagliptin, metformin, and rosiglitazone improves glycemic control in patients with type 2 diabetes
    Dobs, Adrian
    Goldstein, Barry J.
    Wieczorek, Leon
    Golm, Gregory
    Davies, Michael J.
    Williams-Herman, Debora
    Kaufman, Keith D.
    Amatruda, John M.
    Camilo, Juan
    Ferriera, Arjona
    DIABETES, 2008, 57 : A595 - A596
  • [46] Triple combination therapy with sitagliptin, metformin, and rosiglitazone improves glycaemic control in patients with type 2 diabetes
    Ferreira, J. C. Arjona
    Dobs, A.
    Goldstein, B. J.
    Wieczorek, L.
    Golm, G.
    Davies, M. J.
    Williams-Herman, D.
    Kaufman, K. D.
    Amatruda, J. M.
    DIABETOLOGIA, 2008, 51 : S365 - S365
  • [47] Effects of rosiglitazone and metformin treatment on apelin, visfatin, and ghrelin levels in patients with type 2 diabetes mellitus
    Kadoglou, Nikolaos P. E.
    Tsanikidis, Hercules
    Kapelouzou, Alkistis
    Vrabas, Ioannis
    Vitta, Ioulia
    Karayannacos, Panayotis E.
    Liapis, Christos D.
    Sailer, Nikolaos
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2010, 59 (03): : 373 - 379
  • [48] Low-Dose Combination Therapy With Rosiglitazone And Metformin to Prevent Type 2 Diabetes Mellitus (CANOE Trial): A Double-Blind Randomized Controlled Study EDITORIAL COMMENT
    Zinman, Bernard
    Harris, Stewart B.
    Neuman, Jan
    Gerstein, Hertzel C.
    Retnakaran, Ravi R.
    Raboud, Janet
    Qi, Ying
    Hanley, Anthony J. G.
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2010, 65 (12) : 771 - 772
  • [49] Sitagliptin/metformin fixed-dose combination: a guide to its use in type 2 diabetes mellitus
    Drugs & Therapy Perspectives, 2011, 27 (9) : 1 - 5
  • [50] Low-dose rosiglitazone in patients with type 2 diabetes mellitus requiring insulin therapy
    Lopez, Cesar A.
    Kanna, Balavenkatesh
    ARCHIVES OF INTERNAL MEDICINE, 2008, 168 (05) : 548 - 548
12345